SAB Biotherapeutics (SABS) Operating Leases (2020 - 2026)
SAB Biotherapeutics' Operating Leases came in at $1.45 million for Q2 2026, down 35.7% from $2.26 million a year earlier and down 33.2% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics' Operating Leases was $1.88 million, up 223.0% from FY2024.
- Operating Leases carries a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
- Going back by year, Operating Leases was $581,148 in FY2024 (-8.6%), $635,777 in FY2023 (+76.0%), $361,225 in FY2022 (-78.1%) and $1.65 million in FY2021 (-30.3%).
- The Q2 2026 figure represents the lowest quarterly Operating Leases since Q4 2024.
- Year-over-year, Operating Leases increased in four of the last seven quarters, with growth averaging 128.3%.
- The fastest year-over-year change in Operating Leases over five years came in Q2 2024 (growth of 752.2%), and the weakest in Q2 2023 (a decline of 91.3%).
- Business Quant data shows SABS's Operating Leases at $2.17 million (Q1 2026), $1.88 million (Q4 2025) and $2.04 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.35 Mn |
| Jun 30, 2026 | 1.45 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 2.47 Mn |
| Dec 31, 2024 | 581,148.00 |
| Sep 30, 2024 | 682,925.00 |
| Jun 30, 2024 | 782,435.00 |
| Mar 31, 2024 | 554,547.00 |
| Dec 31, 2023 | 635,777.00 |
| Jun 30, 2023 | 91,816.00 |
| Mar 31, 2023 | 227,652.00 |
| Dec 31, 2022 | 361,225.00 |
| Sep 30, 2022 | 762,775.00 |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Dec 31, 2020 | 2.37 Mn |
API Access
SAB Biotherapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();